等待开盘 05-14 09:30:00 美东时间
+0.510
+1.42%
BRIEF-Orion Animal Health Gets FDA Approval For Tessie May 12 (Reuters) - Orion Oyj ORNBV.HE : ORION ANIMAL HEALTH RECEIVES US FDA APPROVAL FOR TESSIE (TASIPIMIDINE ORAL SOLUTION) FOR TREATMENT OF NOISE AVERSION, SEPARATION ANXIETY IN DOGS FDA APPROVES TESSIE (TASIPIMIDINE) FOR DOGS ON MAY 6, 2026 S
05-12 15:31
BRIEF-Roche Receives CE Mark For New Blood Test To Detect Alzheimer's Pathology May 12 (Reuters) - ROCHE HOLDING AG ROPC.S : RECEIVES CE MARK FOR NEW BLOOD TEST TO DETECT ALZHEIMER'S PATHOLOGY Further company coverage: ROPC.S (Gdansk Newsroom) (( gdansk.newsroom@thomsonreuters.com ; +48 587785269;;)
05-12 13:00
BRIEF-Evion To Acquire High-Grade U.S. Fluorspar Project In Nevada May 12 (Reuters) - Evion Group NL EVG.AX : EVION TO ACQUIRE HIGH-GRADE U.S. FLUORSPAR PROJECT IN NEVADA BUYS OPTION TO PURCHASE 100% INTEREST IN 14 LODE CLAIMS IN NEVADA RECEIVES FIRM COMMITMENTS TO RAISE A$6.635 MILLION AT AN ISSUE
05-12 09:37
Sally Beauty Q2 sales slightly beat estimates on e-commerce growth Overview Professional hair color retailer's Q2 net sales grew 2.3%, slightly beating analyst expectations Adjusted EPS for Q2 rose 5% and beat analyst expectations Company repurchased $25 mln in shares and repaid $20 mln in term loan
05-11 18:53
AirSculpt Technologies Q1 revenue flat, outlook reaffirmed Overview U.S. body contouring provider's Q1 revenue was flat yr/yr, case volume up 0.2% Adjusted EPS for Q1 improved yr/yr, adjusted EBITDA declined Company reaffirmed full-year 2026 revenue and adjusted EBITDA guidance Outlook Company reaff
05-08 18:38
BRIEF-Stellantis To Expand Partnership With Leapmotor In Spain May 8 (Reuters) - Stellantis NV STLAM.MI : TO PRODUCE LEAPMOTOR INTERNATIONAL (LMPI) B10 MODEL IN ITS ZARAGOZA PLANT IN SPAIN TO ALSO DEVELOP IN ZARAGOZA PLANT ALL-NEW ELECTRIC BATTERY POWERED OPEL C-SUV MODEL TO EXPAND LPMI’S JOINT PURC
05-08 14:07
US Foods Q1 sales rise 2.8%, slightly miss estimates Overview US foodservice distributor's fiscal Q1 sales up 2.8%, slight miss versus analyst expectations Adjusted EPS for fiscal Q1 rose 14.7% but missed analyst consensus Company repurchased $125 mln of shares during the quarter Outlook US Foods re
05-07 18:54
Bloomin' Brands Q1 revenue up 1%, beats analyst estimates Overview U.S. casual dining operator's Q1 revenue rose 1%, beating analyst expectations Adjusted EPS for Q1 increased to $0.67, beating analyst expectations Revenue growth driven by higher average check and cost-saving initiatives, partly off
05-06 18:40
MPLX's Q1 adjusted EBITDA misses, hurt by derivatives impacts Overview U.S. midstream energy operator's Q1 revenue and net income declined year-over-year Adjusted EBITDA for Q1 missed analyst expectations Company repurchased $50 mln in common units during the quarter Outlook MPLX expects Delaware Ba
05-05 18:58
BRIEF-Nexstim Receives Order From Children Hospital In U.S. May 5 (Reuters) - Nexstim Oyj NXTMH.HE : NEXSTIM RECEIVES NBS 6 SYSTEM ORDER FROM CHILDREN’S HOSPITAL IN THE U.S. Source text: https://mfn.se/ind/a/nexstim/nexstim-receives-nbs-6-system-order-from-childrens-hospital-in-the-u-s-7bb1300f Furt
05-05 14:08